Brooks Laboratories Ltd.

•

brookslabs.netBSE: 533543NSE: BROOKS

Market Cap₹ 194 Cr.

Current Price

High / Low₹ 164 / 36

Stock P/E42.5

Book Value₹ 42

Price to Book0.91

Dividend Yield0.00 %

ROCE5.3 %

ROE4.9 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Manufacturing: 96.7% • Trading: 3.3%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Operating margins have improved to 8.2% from -10.3%
Stock looks reasonably valued - P/E of 42.5 is below its historical median
Company comfortably covers its interest (7.9x coverage)

CONS

Promoter holding has decreased over last 2 years: -11.0pp
Company has a low return on capital employed of 4.4%
Company has a low return on equity of 3.5% over last 3 years
Recent results are weak - TTM profit is down 12.4% versus prior year
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.20x)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	3620.70	2139.42	20263.10	1191.00	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	BROOKS	65.93	14.70	194.21	0.00	-1.79	-101.86	22.96	-9.99	21.72	-5.85

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	16	24	22	18	18	21	21	23	26	23	17	20	23
	16	23	21	17	18	19	19	22	22	21	16	20	22
Operating Profit	0	2	1	0	0	2	2	2	3	3	1	1	1
OPM %	0.13%	7.07%	5.06%	2.14%	1.56%	7.26%	7.70%	6.78%	12.23%	10.75%	4.47%	3.36%	5.41%
	0	0	0	1	0	0	0	1	0	0	0	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Profit before Tax	-1	1	1	0	-0	1	1	2	3	2	0	1	1
Tax %	-0.00%	0.00%	5.00%	0.00%	-0.00%	0.00%	0.00%	11.61%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Profit	-1	1	1	0	-0	1	1	1	3	2	0	1	1
	-0.22	0.46	0.23	0.10	-0.08	0.36	0.36	0.51	0.90	0.76	0.10	0.21	0.48

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	58	56	55	70	77	77	56	79	83	86	83
	52	65	63	74	76	75	61	76	81	79	78
Operating Profit	5	-9	-8	-4	1	2	-6	3	1	7	5
OPM %	8.76%	-16.02%	-15.20%	-5.63%	1.22%	2.44%	-10.47%	3.86%	1.66%	8.23%	6.23%
	0	0	3	0	1	1	0	1	4	1	1
Interest	1	2	3	3	3	1	1	1	1	1	1
Depreciation	2	6	6	7	7	1	2	2	2	2	2
Profit before Tax	2	-18	-15	-14	-8	1	-8	2	3	6	5
Tax %	32.86%	21.22%	0.95%	-80.38%	-84.79%	0.00%	-0.00%	1.67%	5.43%	0.00%	0.00%
Net Profit	2	-14	-15	-24	-16	1	-8	2	3	6	5
EPS	0.00	0.00	0.00	0.00	-6.31	0.27	-3.32	0.58	1.04	1.97	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: 1%
5 Years:: 2%
3 Years:: 16%

COMPOUNDED PROFIT GROWTH

10 Years:: -6%
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: -4%
5 Years:: -11%
3 Years:: -14%
1 Year:: -55%

RETURN ON EQUITY

10 Years:: -7%
5 Years:: 0%
3 Years:: 4%
Last Year:: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16	16	16	25	25	25	25	26	29	29
	112	98	83	74	40	40	32	43	86	91
	14	28	31	27	9	6	7	6	8	9
Trade Payables	18	27	27	26	13	26	23	15	14	11
	-3	-7	-1	6	7	6	5	3	4	6
Total Liabilities	158	162	157	158	93	103	92	94	141	146
	125	124	117	113	15	15	15	14	14	15
Capital Work in Progress	0	1	0	0	0	1	0	0	0	1
	1	1	0	0	47	47	47	47	91	91
	8	11	10	14	12	17	11	10	9	11
	0	0	0	0	0	0	0	16	20	16
Cash & Bank	2	2	3	2	1	1	1	1	1	8
	22	23	26	30	18	23	18	7	6	5
Total Assets	158	162	157	158	93	103	92	94	141	146

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	11	-5	-4	-9	3	3	1	-10	3	9
Cash from Investing	-17	-5	1	-2	-1	1	-0	0	-45	-3
Cash from Financing	7	12	6	10	1	-4	-0	10	42	0
	-0	1	2	-2	-0	0	-0	0	-0	7

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	1.03	-8.53	-9.15	-9.87	-6.31	0.27	-3.31	0.58	1.04	1.97
Book Value (₹)	79.25	70.72	61.53	39.84	25.99	26.31	22.98	26.49	39.06	41.02
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	1.70	-3.76	-4.24	-7.11	-3.41	0.86	-2.59	1.26	1.58	2.51
PROFITABILITY
Operating Margin %	7.96%	-15.26%	-9.97%	-5.05%	2.47%	3.67%	-10.26%	3.85%	1.66%	8.23%
Net Margin %	2.57%	-24.27%	-26.90%	-34.98%	-20.17%	0.87%	-14.73%	1.92%	3.70%	6.77%
ROE %	1.33%	-11.38%	-13.83%	-24.62%	-19.17%	1.03%	-13.44%	2.42%	3.31%	4.92%
ROCE %	2.59%	-10.64%	-8.60%	-7.77%	-5.24%	1.87%	-11.21%	3.50%	4.35%	5.33%
	1.06%	-8.64%	-9.29%	-15.48%	-12.43%	0.68%	-8.36%	1.64%	2.60%	4.04%
EFFICIENCY
Debtor Days	83	67	72	71	59	58	91	67	80	77
Inventory Days	40	61	71	62	62	69	92	48	42	43
Payable Days	170	209	249	207	151	145	222	125	98	90
	-46	-80	-106	-74	-30	-18	-39	-10	24	30
FINANCIAL HEALTH
Debt to Equity (x)	0.11x	0.24x	0.31x	0.27x	0.13x	0.08x	0.10x	0.07x	0.05x	0.06x
Interest Coverage (x)	3.46x	-6.29x	-4.05x	-3.03x	-1.60x	1.99x	-9.67x	2.84x	4.14x	7.95x
	0.90x	0.76x	0.67x	0.83x	0.99x	1.04x	0.84x	1.35x	1.48x	1.72x
GROWTH
Revenue Growth %	-28.08%	-3.18%	-1.22%	26.64%	10.89%	-0.40%	-27.84%	43.12%	3.86%	3.85%
Operating Profit Growth %	-59.16%	-268.17%	36.84%	35.91%	154.19%	48.12%	-301.95%	173.22%	40.36%	40.51%
Net Profit Growth %	-84.32%	-928.65%	-7.19%	-64.64%	36.05%	104.27%	-1328.69%	118.68%	99.62%	90.19%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	117.58%	77.87%	90.20%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	159.31x	103.99x	19.02x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	3.50x	2.76x	0.91x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	59.41x	55.01x	13.39x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	63.59	63.59	59.06	52.62	52.62	52.62	52.62	52.62	52.62
	0.00	0.02	0.01	0.05	0.00	0.01	0.09	0.17	0.00
	3.86	3.86	3.86	9.90	9.90	9.90	9.90	9.90	9.90
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	32.55	32.53	37.08	37.43	37.48	37.48	37.39	37.32	37.48

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04

Shareholders meeting

2026-09-04 - Brooks Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 03, 2026. Further, the company has informed the Exchange regarding voting results.

2026-09-03

Shareholders meeting

2026-09-03 - Brooks Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 03, 2026

2026-08-22

Copy of Newspaper Publication

2026-08-22 - Please find enclosed herewith Addendum to the Notice of 24th Annual General Meeting.

2026-08-21

Shareholders meeting

2026-08-21 - Addendum to the Notice of 24th Annual General Meeting of the Company.

2026-08-17

Updates

2026-08-17 - Brooks Laboratories Limited has informed the Exchange regarding 'Intimation Of Record Date, E-Voting Dates And Book Closure Date'.

2026-08-14

Copy of Newspaper Publication

2026-08-14 - Brooks Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-13

Outcome of Board Meeting

2026-08-13 - Brooks Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-13

Copy of Newspaper Publication

2026-08-13 - Newspaper publication regarding 24th AGM of the Company to be held on 3rd September 2026.

2026-08-12

General Updates

2026-08-12 - Letter to Shareholders - Annual Report for the FY 2025-26.

News

Recent coverage and analyst commentary for BROOKS

Loading news…

🤖

AI Stock Analyst

Brooks Laboratories Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1899.00

37.67

455633.71

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9100.00

82.59

241576.41

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4850.00

84.58

184478.41

0.78

566.00

3.28

4921.00

57.32

19.27

33.81

CIPLA

1385.00

33.19

111888.39

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

ZYDUSLIFE

1121.00

24.78

111820.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

LAURUSLABS

1840.00

90.93

99417.45

0.11

3620.70

2139.42

20263.10

1191.00

18.20

31.50

LUPIN

2111.00

17.46

96528.82

0.85

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1154.00

29.89

96322.06

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2328.55

47.09

96179.61

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1653.30

25.62

95127.23

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2427.00

38.10

68495.93

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

BROOKS

65.93

14.70

194.21

0.00

-1.79

-101.86

22.96

-9.99

21.72

-5.85

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

OPM %

0.13%

7.07%

5.06%

2.14%

1.56%

7.26%

7.70%

6.78%

12.23%

10.75%

4.47%

3.36%

5.41%

Interest

Depreciation

Profit before Tax

-1

-0

Tax %

-0.00%

0.00%

5.00%

0.00%

-0.00%

0.00%

11.61%

0.00%

Net Profit

-1

-0

-0.22

0.46

0.23

0.10

-0.08

0.36

0.51

0.90

0.76

0.10

0.21

0.48

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

Operating Profit

-9

-8

-4

-6

OPM %

8.76%

-16.02%

-15.20%

-5.63%

1.22%

2.44%

-10.47%

3.86%

1.66%

8.23%

6.23%

Interest

Depreciation

Profit before Tax

-18

-15

-14

-8

Tax %

32.86%

21.22%

0.95%

-80.38%

-84.79%

0.00%

-0.00%

1.67%

5.43%

0.00%

Net Profit

-14

-15

-24

-16

-8

EPS

0.00

-6.31

0.27

-3.32

0.58

1.04

1.97

—

Dividend Payout %

0.00%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

112

Trade Payables

-3

-7

-1

Total Liabilities

158

162

157

158

103

141

146

125

124

117

113

Capital Work in Progress

Cash & Bank

Total Assets

158

162

157

158

103

141

146

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-5

-4

-9

-10

Cash from Investing

-17

-5

-2

-1

-0

-45

-3

Cash from Financing

-4

-0

-2

-0

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

1.03

-8.53

-9.15

-9.87

-6.31

0.27

-3.31

0.58

1.04

1.97

Book Value (₹)

79.25

70.72

61.53

39.84

25.99

26.31

22.98

26.49

39.06

41.02

Dividend per Share (₹)

0.00

Cash EPS (₹)

1.70

-3.76

-4.24

-7.11

-3.41

0.86

-2.59

1.26

1.58

2.51

PROFITABILITY

Operating Margin %

7.96%

-15.26%

-9.97%

-5.05%

2.47%

3.67%

-10.26%

3.85%

1.66%

8.23%

Net Margin %

2.57%

-24.27%

-26.90%

-34.98%

-20.17%

0.87%

-14.73%

1.92%

3.70%

6.77%

ROE %

1.33%

-11.38%

-13.83%

-24.62%

-19.17%

1.03%

-13.44%

2.42%

3.31%

4.92%

ROCE %

2.59%

-10.64%

-8.60%

-7.77%

-5.24%

1.87%

-11.21%

3.50%

4.35%

5.33%

1.06%

-8.64%

-9.29%

-15.48%

-12.43%

0.68%

-8.36%

1.64%

2.60%

4.04%

EFFICIENCY

Debtor Days

Inventory Days

Payable Days

170

209

249

207

151

145

222

125

-46

-80

-106

-74

-30

-18

-39

-10

FINANCIAL HEALTH

Debt to Equity (x)

0.11x

0.24x

0.31x

0.27x

0.13x

0.08x

0.10x

0.07x

0.05x

0.06x

Interest Coverage (x)

3.46x

-6.29x

-4.05x

-3.03x

-1.60x

1.99x

-9.67x

2.84x

4.14x

7.95x

0.90x

0.76x

0.67x

0.83x

0.99x

1.04x

0.84x

1.35x

1.48x

1.72x

GROWTH

Revenue Growth %

-28.08%

-3.18%

-1.22%

26.64%

10.89%

-0.40%

-27.84%

43.12%

3.86%

3.85%

Operating Profit Growth %

-59.16%

-268.17%

36.84%

35.91%

154.19%

48.12%

-301.95%

173.22%

40.36%

40.51%

Net Profit Growth %

-84.32%

-928.65%

-7.19%

-64.64%

36.05%

104.27%

-1328.69%

118.68%

99.62%

90.19%

0.00%

117.58%

77.87%

90.20%

VALUATION

P/E (x)

0.00x

159.31x

103.99x

19.02x

P/B (x)

0.00x

3.50x

2.76x

0.91x

Dividend Yield %

0.00%

0.00x

59.41x

55.01x

13.39x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

63.59

59.06

52.62

0.00

0.02

0.01

0.05

0.00

0.01

0.09

0.17

0.00

3.86

9.90

Government

0.00

32.55

32.53

37.08

37.43

37.48

37.39

37.32

37.48

Brooks Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Brooks Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI